Capricor Therapeutics, Inc. (CAPR) vs Puma Biotechnology, Inc. (PBYI)

• Capricor Therapeutics, Inc. CAPR 9.04 ▲ +5.12%
• Puma Biotechnology, Inc. PBYI 8.27 ▼ −15.35%

Capricor Therapeutics, Inc. and Puma Biotechnology, Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. and Puma Biotechnology, Inc. are of similar size ($504.3M and $500.0M). Capricor Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 15.3×. Puma Biotechnology, Inc. grew revenue faster over the last twelve months: −2.86% against −11.6%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs −1,019.7%). Across the 18 metrics below, Puma Biotechnology, Inc. leads on 12 and Capricor Therapeutics, Inc. on 6.